ARCHIVES

Also FDA clarifies data requirements for phase I IND applications.

This article is from The Cancer Letter archive.

Vol. 31 No. 17 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002

Abstracts From AACR Annual Meeting

June 4, 1976

ASCO 2011 Award Winners

June 10, 2011

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

Varmus: Why are scientific societies obstructing public access to research results?

May 20, 2005

House subcommittee proposes 2.8 percent increase for NIH, NCI.

July 16, 2004